Opinion

Video

Advances in Anti-HER2 ADCs in Patients With Advanced or Recurrent Endometrial Cancer

Key opinion leaders share excitement about antibody-drug conjugates targeting HER2 in advanced or recurrent endometrial cancer, and debate optimal HER2 testing methods, with some preferring gastric cancer scoring criteria over breast cancer criteria.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.